e-learning
resources
Munich 2006
Monday 04.09.2006
Various parenchymal lung diseases and pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Wegener‘s granulomatosis – an analysis of 5 cases
I. N. Hiuhiu, C. L. Toma, T. Constantinescu, S. Dumitrache-Rujinski, C. E. Tudose, D. Bumbacea, M. A. Bogdan (Bucharest, Romania)
Source:
Annual Congress 2006 - Various parenchymal lung diseases and pulmonary hypertension
Session:
Various parenchymal lung diseases and pulmonary hypertension
Session type:
Poster Discussion
Number:
2274
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. N. Hiuhiu, C. L. Toma, T. Constantinescu, S. Dumitrache-Rujinski, C. E. Tudose, D. Bumbacea, M. A. Bogdan (Bucharest, Romania). Wegener‘s granulomatosis – an analysis of 5 cases. Eur Respir J 2006; 28: Suppl. 50, 2274
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Wegener granulomatosis : review of 16 cases
Source: Eur Respir J 2002; 20: Suppl. 38, 314s
Year: 2002
Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012
Wegener's granulomatosis (WG) - clinical features and response to treatment in 18 cases
Source: Eur Respir J 2002; 20: Suppl. 38, 64s
Year: 2002
Wegener‘s granulomatosis (WG) limited to the lungs
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004
Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020
Granulomatosis with polyangiitis (Wegener&s)
Source: Eur Respir Mon 2011; 54: 1-14
Year: 2011
New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA)
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017
Horner‘s syndrome in Wegener‘s granulomatosis: case report
Source: Eur Respir J 2007; 30: Suppl. 51, 87s
Year: 2007
Wegener's granulomatosis: our experience
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001
Physiological characteristics in patients with microscopic polyangitis (MPA) and wegener‘s granulomatosis (WG)
Source: Eur Respir J 2004; 24: Suppl. 48, 327s
Year: 2004
Radiological findings in patients with Wegener granulomatosis
Source: Eur Respir J 2003; 22: Suppl. 45, 593s
Year: 2003
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020
Year: 2020
Eosinophilic granulomatosis with polyangiitis
Source: Eur Respir Monogr 2019; 86: 188-209
Year: 2019
Eosinophilic granulomatosis with polyangiitis
Source: Eur Respir Monogr 2022; 95: 177-192
Year: 2022
Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis
Source: International Congress 2019 – Pulmonary vascular diseases?
Year: 2019
Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases
Source: International Congress 2014 – ILDs 6
Year: 2014
The presence of staphylococcal superantigens in nasal swabs and correlation with activity of granulomatosis with polyangiitis (GPA) in own material.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab
Source: Eur Respir J 2006; 27: 644-646
Year: 2006
Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
Microscopic polyangiitis and granulomatosis with polyangiitis
Source: Eur Respir Monogr 2019; 86: 153-172
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept